These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. First evidence of treatment efficacy in metastatic carcinoma of the parotid gland with BRD4/NUT translocation. Vulsteke C; Lurquin E; Debiec-Rychter M; Gheysens O; Nuyts S; Schoenaers J; Politis C; Mebis J; Hauben E; Clement PM J Chemother; 2016 Jun; 28(3):242-6. PubMed ID: 26027633 [TBL] [Abstract][Full Text] [Related]
3. Novel BRD4-NUT fusion isoforms increase the pathogenic complexity in NUT midline carcinoma. Thompson-Wicking K; Francis RW; Stirnweiss A; Ferrari E; Welch MD; Baker E; Murch AR; Gout AM; Carter KW; Charles AK; Phillips MB; Kees UR; Beesley AH Oncogene; 2013 Sep; 32(39):4664-74. PubMed ID: 23128391 [TBL] [Abstract][Full Text] [Related]
4. A rare Japanese case with a NUT midline carcinoma in the nasal cavity: a case report with immunohistochemical and genetic analyses. Suzuki S; Kurabe N; Minato H; Ohkubo A; Ohnishi I; Tanioka F; Sugimura H Pathol Res Pract; 2014 Jun; 210(6):383-8. PubMed ID: 24655834 [TBL] [Abstract][Full Text] [Related]
5. Midline carcinoma with t(15;19) and BRD4-NUT fusion oncogene in a 30-year-old female with response to docetaxel and radiotherapy. Engleson J; Soller M; Panagopoulos I; Dahlén A; Dictor M; Jerkeman M BMC Cancer; 2006 Mar; 6():69. PubMed ID: 16542442 [TBL] [Abstract][Full Text] [Related]
6. [Utility of NUT gene expression and rearrangement in diagnosis of NUT midline carcinoma in upper respiratory tract]. Fang W; French CA; Cameron MJ; Han YD; Liu HG Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):519-24. PubMed ID: 23157742 [TBL] [Abstract][Full Text] [Related]
7. The first report of molecular characterized BRD4-NUT carcinoma in Brazil: a case report. Oliveira LJC; Gongora ABL; Latancia MT; Barbosa FG; Gregorio JVAM; Testagrossa LA; Amano MT; Feher O J Med Case Rep; 2019 Sep; 13(1):279. PubMed ID: 31492174 [TBL] [Abstract][Full Text] [Related]
8. Clinical Response of Carcinomas Harboring the BRD4-NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628. Stathis A; Zucca E; Bekradda M; Gomez-Roca C; Delord JP; de La Motte Rouge T; Uro-Coste E; de Braud F; Pelosi G; French CA Cancer Discov; 2016 May; 6(5):492-500. PubMed ID: 26976114 [TBL] [Abstract][Full Text] [Related]
9. A case of NUT midline carcinoma with complete response to gemcitabine following cisplatin and docetaxel. Ueki H; Maeda N; Sekimizu M; Yamashita Y; Moritani S; Horibe K J Pediatr Hematol Oncol; 2014 Nov; 36(8):e476-80. PubMed ID: 24322502 [TBL] [Abstract][Full Text] [Related]
10. Midline carcinoma of children and young adults with NUT rearrangement. French CA; Kutok JL; Faquin WC; Toretsky JA; Antonescu CR; Griffin CA; Nose V; Vargas SO; Moschovi M; Tzortzatou-Stathopoulou F; Miyoshi I; Perez-Atayde AR; Aster JC; Fletcher JA J Clin Oncol; 2004 Oct; 22(20):4135-9. PubMed ID: 15483023 [TBL] [Abstract][Full Text] [Related]
11. Complex chromosomal rearrangements by single catastrophic pathogenesis in NUT midline carcinoma. Lee JK; Louzada S; An Y; Kim SY; Kim S; Youk J; Park S; Koo SH; Keam B; Jeon YK; Ku JL; Yang F; Kim TM; Ju YS Ann Oncol; 2017 Apr; 28(4):890-897. PubMed ID: 28203693 [TBL] [Abstract][Full Text] [Related]
12. BRD4 bromodomain gene rearrangement in aggressive carcinoma with translocation t(15;19). French CA; Miyoshi I; Aster JC; Kubonishi I; Kroll TG; Dal Cin P; Vargas SO; Perez-Atayde AR; Fletcher JA Am J Pathol; 2001 Dec; 159(6):1987-92. PubMed ID: 11733348 [TBL] [Abstract][Full Text] [Related]
13. NUT Carcinoma of the Sublingual Gland. Andreasen S; French CA; Josiassen M; Hahn CH; Kiss K Head Neck Pathol; 2016 Sep; 10(3):362-6. PubMed ID: 26586234 [TBL] [Abstract][Full Text] [Related]
14. The importance of diagnosing NUT midline carcinoma. French CA Head Neck Pathol; 2013 Mar; 7(1):11-6. PubMed ID: 23463074 [TBL] [Abstract][Full Text] [Related]
15. Clinicopathological significance of NUT rearrangements in poorly differentiated malignant tumors of the upper respiratory tract. Fang W; French CA; Cameron MJ; Han Y; Liu H Int J Surg Pathol; 2013 Apr; 21(2):102-10. PubMed ID: 22777717 [TBL] [Abstract][Full Text] [Related]
16. Cytologic findings of NUT midline carcinoma in the hilum of the lung. Policarpio-Nicolas ML; de Leon EM; Jagirdar J Diagn Cytopathol; 2015 Sep; 43(9):739-42. PubMed ID: 26138851 [TBL] [Abstract][Full Text] [Related]
17. NUT midline carcinoma of the parotid gland with mesenchymal differentiation. den Bakker MA; Beverloo BH; van den Heuvel-Eibrink MM; Meeuwis CA; Tan LM; Johnson LA; French CA; van Leenders GJ Am J Surg Pathol; 2009 Aug; 33(8):1253-8. PubMed ID: 19561446 [TBL] [Abstract][Full Text] [Related]
18. NSD3-NUT-expressing midline carcinoma of the lung: first characterization of primary cancer tissue. Suzuki S; Kurabe N; Ohnishi I; Yasuda K; Aoshima Y; Naito M; Tanioka F; Sugimura H Pathol Res Pract; 2015 May; 211(5):404-8. PubMed ID: 25466466 [TBL] [Abstract][Full Text] [Related]
19. Demystified molecular pathology of NUT midline carcinomas. French CA J Clin Pathol; 2010 Jun; 63(6):492-6. PubMed ID: 18552174 [TBL] [Abstract][Full Text] [Related]